Huang, Q. ., Aluise, C. ., Joshi, G. ., Sultana, R. ., St Clair, D. ., Markesbery, W. ., & Butterfield, D. . (2010). Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. Journal of Neuroscience Research, 88(12), 2618-29. https://doi.org/10.1002/jnr.22422

Aluise, C. ., Robinson, R. ., Cai, J. ., Pierce, W. ., Markesbery, W. ., & Butterfield, D. . Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: insights into memory loss in MCI. Journal of Alzheimer’s Disease : JAD, 23(2), 257-69. https://doi.org/10.3233/JAD-2010-101083 (Original work published 2011)

Russell, M. ., White, R. ., Patel, E. ., Markesbery, W. ., Watson, C. ., & Geddes, J. . (1992). Familial influence on plaque formation in the beagle brain. Neuroreport, 3(12), 1093-6. https://doi.org/10.1097/00001756-199212000-00015

Tekirian, T. ., Cole, G. ., Russell, M. ., Yang, F. ., Wekstein, D. ., Patel, E. ., … Geddes, J. . (1969). Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiology of Aging, 17(2), 249-57. https://doi.org/10.1016/0197-4580(95)02062-4 (Original work published 1969)

Geddes, J. ., Tekirian, T. ., Soultanian, N. ., Ashford, J. ., Davis, D. ., & Markesbery, W. . (1969). Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease. Neurobiology of Aging, 18(4 Suppl), S99-105. https://doi.org/10.1016/s0197-4580(97)00063-8 (Original work published 1969)

Tekirian, T. ., Saido, T. ., Markesbery, W. ., Russell, M. ., Wekstein, D. ., Patel, E. ., & Geddes, J. . (1998). N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. Journal of Neuropathology and Experimental Neurology, 57(1), 76-94. https://doi.org/10.1097/00005072-199801000-00009

Aksenov, M. ., Aksenova, M. ., Butterfield, D. ., Geddes, J. ., & Markesbery, W. . Protein oxidation in the brain in Alzheimer’s disease. Neuroscience, 103(2), 373-83. https://doi.org/10.1016/s0306-4522(00)00580-7 (Original work published 2001)

Blalock, E. ., Geddes, J. ., Chen, K. ., Porter, N. ., Markesbery, W. ., & Landfield, P. . (2004). Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the United States of America, 101(7), 2173-8. https://doi.org/10.1073/pnas.0308512100 (Original work published 2004)

Robinson, R. ., Joshi, G. ., Huang, Q. ., Sultana, R. ., Baker, A. ., Cai, J. ., … Butterfield, D. . (2011). Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild.. Proteomics, 11(21), 4243-56. https://doi.org/10.1002/pmic.201000523

Aksenov, M. ., Tucker, H. ., Nair, P. ., Aksenova, M. ., Butterfield, D. ., Estus, S. ., & Markesbery, W. . (1998). The expression of key oxidative stress-handling genes in different brain regions in Alzheimer’s disease. Journal of Molecular Neuroscience : MN, 11(2), 151-64. https://doi.org/10.1385/JMN:11:2:151